The evolving healthcare landscape, influenced by factors such as expanded health insurance coverage from the Affordable Care Act, rising acute and chronic illness rates, and modernization of healthcare facilities, is driving growth in medical imaging products. While cost containment efforts may impact pricing, tests improving therapeutic outcomes are expected to thrive. In Kalorama Information’s report […]
Over the next five years, projections indicate a continued increase in total consumer out-of-pocket expenditures for healthcare, maintaining the upward trajectory observed in recent years. Despite a temporary slowdown during the COVID-19 pandemic of 2020 and 2021, the historical trend resumed in 2022 and persisted through 2023, with expectations for ongoing growth. These insights stem […]
“Advances in Medtech can enhance patient treatment, improve outcomes, lower hospital admissions and fatalities, achieve cost savings, and alleviate the workload on healthcare staff, thus creating a market for medical devices that is forecast to grow and expand over the next five years.“ – Kalorama Information The world market for Medtech is valued at over $500 billion […]
The global market for LIS is forecast to increase at a high single-digit compound annual growth rate (CAGR) between 2022 and 2027, reveals leading medical market research publisher Kalorama Information in the new report World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027. Advances in healthcare will function as […]
The in vitro diagnostic (IVD) industry is on track again after the disruptions of the pandemic. The overall volume of IVD procedures will rise steadily throughout most of the world, boosted by aging population trends, proliferating epidemiological patterns, increasing availability of healthcare funding, and widespread adoption of patient care strategies that emphasize early disease detection […]
This blog is based on the August 2023 market research report The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition, now on sale from Kalorama Information Artificial intelligence systems, which simulate human intelligence by learning, reasoning, and self-correction, have the potential to be more accurate than doctors at making diagnoses and performing surgical interventions. […]
Out-of-pocket expenditures (OOP) have long weighed upon the United States healthcare system and consumers. The weight is as heavy as ever in 2023 as OOP healthcare spending by consumers will reach an estimated $519 billion by year’s end, up almost 9% from 2022 with continued annual growth of 10% forecast through 2028. These findings are […]
“The United States is the biggest user of blood transfusions—approximately 5 million people in the U.S. receive blood and blood components through 10.9 million transfusions per year.” – Kalorama Information The global $2.5 billion blood screening market is evolving on many levels, and despite it’s maturity the industry is poised for growth through 2026 […]
By Daniel Granderson In 2021, total U.S. out-of-pocket healthcare spending by consumers reached an estimated $491.6 billion, up about 10% from the prior year with continued annual growth of 9.9% expected through 2026. This will result in almost $800 billion of consumer out-of-pocket healthcare spending in 2026, reports leading medical market research publisher Kalorama […]
This infographic is based on the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others) by leading medical market research publisher Kalorama Information. Purchase the report for more insights on the past, present, and future of this important market.
